Singapore: Researchers at nine sites have begun testing in humans an investigational H7N9 avian influenza vaccine. The t...
Singapore: In a bid to curtail the growing cases of influenza in Japan, Astellas announced that it has submitted an app...
Singapore: Researchers at the Institute for Cell Dynamics and Biotech at Universidad de Chile are developing a new vacci...
Singapore: Australian schoolboys have begun receiving the first-of-three vaccinations to protect them against cancers a...
Singapore: WHO along with European Respiratory Society (ERS), has outlined a framework to work on pre-elimination of tub...
Singapore: Patrys, a clinical stage biopharmaceutical company, has confirmed anti-cancer properties of PAT-SM6 and has d...
Singapore: Germany's Riboxx Pharmaceuticals and China National Biotec Group (CNBG) have initiated a research collaborati...
Singapore: Roche and Inovio Pharmaceuticals entered into an exclusive worldwide license agreement to R&D and commerc...
Singapore: Australian vaccine development company BioDiem announced that it has begun research collaboration with France...
Singapore: Daiichi Sankyo's animal vaccine unit, Kitasato Daiichi Sankyo Vaccine is discontinuing its animal vaccine bus...
Singapore: The editor of Nature Medicine has acknowledged Lindsley F Kimball Research Institute, which is located at NYB...
Singapore: Inovio Pharmaceuticals revealed that its SynCon DNA vaccine has demonstrated strong and durable antibody and ...
Singapore: China based manufacturer and supplier of refrigeration and cold chain equipments, AUCMA, has partnered with G...
Scientist, entrepreneur, administrator, adviser. Dr Chi-Huey Wong, the ninth president of Academia Sinica, has donned ma...
Singapore: A pneumococcal vaccine, Synflorix, by GlaxoSmithKline will be be introduced into the national immunization pr...
Singapore: A research team led by Academia Sinica President, Dr. Chi-Huey Wong, and associate research fellow, Dr Chung-...
Singapore: Bahrain's health ministry has almost doubled its annual order of flu vaccines following fears of MERS corona...
Pune: The phase III trial of RotaVac, India's first indigenously developed rotavirus vaccine, has been completed and the...
